Quarterly report · Q2
6856.TEDINET S100P17D
Period2022-01-01 → 2022-06-30
Filed2022-08-15
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥115.0bn | 2022-01-01 → 2022-06-30 | Cons. | Net sales |
| Revenue | ¥224.3bn | 2021-01-01 → 2021-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥101.3bn | 2021-01-01 → 2021-06-30 | Cons. | Net sales |
| Operating income | ¥16.3bn | 2022-01-01 → 2022-06-30 | Cons. | Operating income |
| Operating income | ¥13.1bn | 2021-01-01 → 2021-06-30 | Cons. | Operating income |
| Ordinary income | ¥16.8bn | 2022-01-01 → 2022-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥32.0bn | 2021-01-01 → 2021-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥13.0bn | 2021-01-01 → 2021-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥16.8bn | 2022-01-01 → 2022-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥13.0bn | 2021-01-01 → 2021-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥11.2bn | 2022-01-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥21.3bn | 2021-01-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥8.7bn | 2021-01-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥11.2bn | 2022-01-01 → 2022-06-30 | Cons. | Profit loss |
| Net income | ¥8.7bn | 2021-01-01 → 2021-06-30 | Cons. | Profit loss |
| Total assets | ¥398.4bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥371.6bn | at 2021-12-31 | Cons. | Assets |
| Total assets | ¥349.0bn | at 2021-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥173.8bn | at 2022-06-30 | Cons. | Liabilities |
| Total liabilities | ¥167.1bn | at 2021-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥224.6bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥204.5bn | at 2021-12-31 | Cons. | Net assets |
| Net assets / equity | ¥191.6bn | at 2021-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥140.0bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥135.0bn | at 2021-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥139.3bn | at 2022-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥133.9bn | at 2021-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥122.0bn | at 2021-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥114.2bn | at 2020-12-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥10.3bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥35.3bn | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥15.8bn | 2021-01-01 → 2021-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥3.1bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥14.7bn | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥6.9bn | 2021-01-01 → 2021-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥6.9bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥4.0bn | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥3.1bn | 2021-01-01 → 2021-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥266.31 | 2022-01-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥130.72 | 2022-04-01 → 2022-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥505.05 | 2021-01-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥207.24 | 2021-01-01 → 2021-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥114.81 | 2021-04-01 → 2021-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥264.93 | 2022-01-01 → 2022-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥502.46 | 2021-01-01 → 2021-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥206.2 | 2021-01-01 → 2021-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 56.2% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.8% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.7% | at 2021-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E01901-000Automotivereportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥25.7bn |
| jpcrp040300-q2r_E01901-000Automotivereportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥25.7bn |
| jpcrp040300-q2r_E01901-000Automotivereportable segment | segment profit | 2022-01-01 → 2022-06-30 | −¥1.8bn |
| jpcrp040300-q2r_E01901-000Medical Diagnosticsreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥13.7bn |
| jpcrp040300-q2r_E01901-000Medical Diagnosticsreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥13.7bn |
| jpcrp040300-q2r_E01901-000Medical Diagnosticsreportable segment | segment profit | 2022-01-01 → 2022-06-30 | −¥162m |
| jpcrp040300-q2r_E01901-000Process And Environmentalreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥10.2bn |
| jpcrp040300-q2r_E01901-000Process And Environmentalreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥10.2bn |
| jpcrp040300-q2r_E01901-000Process And Environmentalreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥638m |
| jpcrp040300-q2r_E01901-000Scientificreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥16.0bn |
| jpcrp040300-q2r_E01901-000Scientificreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥16.0bn |
| jpcrp040300-q2r_E01901-000Scientificreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥765m |
| jpcrp040300-q2r_E01901-000Semiconductorreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥49.4bn |
| jpcrp040300-q2r_E01901-000Semiconductorreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥49.4bn |
| jpcrp040300-q2r_E01901-000Semiconductorreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥16.8bn |
| jpcrp040300-q2r_E01901-000Automotivereportable segment | revenue | 2021-01-01 → 2021-06-30 | ¥24.9bn |
| jpcrp040300-q2r_E01901-000Automotivereportable segment | revenue external | 2021-01-01 → 2021-06-30 | ¥24.9bn |
| jpcrp040300-q2r_E01901-000Automotivereportable segment | segment profit | 2021-01-01 → 2021-06-30 | −¥1.2bn |
| jpcrp040300-q2r_E01901-000Medical Diagnosticsreportable segment | revenue | 2021-01-01 → 2021-06-30 | ¥12.9bn |
| jpcrp040300-q2r_E01901-000Medical Diagnosticsreportable segment | revenue external | 2021-01-01 → 2021-06-30 | ¥12.9bn |
| jpcrp040300-q2r_E01901-000Medical Diagnosticsreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥326m |
| jpcrp040300-q2r_E01901-000Process And Environmentalreportable segment | revenue | 2021-01-01 → 2021-06-30 | ¥10.0bn |
| jpcrp040300-q2r_E01901-000Process And Environmentalreportable segment | revenue external | 2021-01-01 → 2021-06-30 | ¥10.0bn |
| jpcrp040300-q2r_E01901-000Process And Environmentalreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥1.1bn |
| jpcrp040300-q2r_E01901-000Scientificreportable segment | revenue | 2021-01-01 → 2021-06-30 | ¥13.4bn |
| jpcrp040300-q2r_E01901-000Scientificreportable segment | revenue external | 2021-01-01 → 2021-06-30 | ¥13.4bn |
| jpcrp040300-q2r_E01901-000Scientificreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥464m |
| jpcrp040300-q2r_E01901-000Semiconductorreportable segment | revenue | 2021-01-01 → 2021-06-30 | ¥40.0bn |
| jpcrp040300-q2r_E01901-000Semiconductorreportable segment | revenue external | 2021-01-01 → 2021-06-30 | ¥40.0bn |
| jpcrp040300-q2r_E01901-000Semiconductorreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥12.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 560
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)有限責任 あずさ監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)羽津 隆弘 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)山田 徹雄 | |
| Cpa3 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)山中 智弘 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 101317000000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 114965000000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 224314000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 13047000000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 16784000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 32038000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 8744000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 11240000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 21311000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 15294000000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 24205000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 30343000000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 191554000000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 224647000000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 204493000000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 348968000000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 398397000000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 371585000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 207.24 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 266.31 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 505.05 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | 206.20 | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | 264.93 | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | 502.46 | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.5466 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.5619 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.5482 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1YTDDuration | 15821000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYTDDuration | 10273000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 35268000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YTDDuration | -6942000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYTDDuration | -3080000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -14662000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YTDDuration | -3108000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYTDDuration | -6921000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | -4045000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1QuarterInstant | 121960000000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentQuarterInstant | 139255000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 133938000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1QuarterDuration | 114.81 | |
| Basic earnings loss per share (5-year summary) | CurrentQuarterDuration | 130.72 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 42532752 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 42532752 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 42532752 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |